MET in Gastric Cancer - Discarding a 10% Cutoff Rule

Histopathology - United Kingdom
doi 10.1111/his.12745
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

MET Mutation and Familial Gastric Cancer

Journal of Medical Genetics
Genetics
2001English

Adjuvant Chemoradiation for Resected Gastric Cancer: A 10-Year Experience

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2011English

Prognostic Significance of MET Amplification and Expression in Gastric Cancer: A Systematic Review With Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Exposure-Response Analysis of Rilotumumab in Gastric Cancer: The Role of Tumour MET Expression

British Journal of Cancer
Cancer ResearchOncology
2015English

A Meta-Analysis of Interleukin-10 -592 Promoter Polymorphism Associated With Gastric Cancer Risk

PLoS ONE
Multidisciplinary
2012English

Is a Cutoff of 10% Appropriate for the Change-In-Estimate Criterion of Confounder Identification?

Journal of Epidemiology
MedicineEpidemiology
2014English

Forty-Nine Gastric Cancer Cell Lines With Integrative Genomic Profiling for Development of C-Met Inhibitor

International Journal of Cancer
Cancer ResearchOncology
2018English

When Lisbon Met the Team 10 Cluster City

Joelho Revista de Cultura Arquitectonica
2019English

Physical Basis of the ‘Magnification Rule’ for Standardized Immunohistochemical Scoring of HER2 in Breast and Gastric Cancer

Diagnostic Pathology
Forensic MedicineMedicinePathologyHistology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy